Aurobindo Pharma Board Meeting Nov 4 for Q2 Results & Dividend

Aurobindo Pharma Ltd has announced a Board of Directors meeting scheduled for November 4, 2026. The meeting will primarily focus on approving the standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2026. Additionally, the board will consider the payment of an interim dividend for the financial year 2026-27. The trading window, initially closed from October 1, 2026, will remain closed until November 6, 2026, and will reopen on November 7, 2026.